Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-07-02 @ 10:09 PM
Study NCT ID:
NCT02110992
Status:
TERMINATED
Last Update Posted:
2019-11-25
First Post:
2014-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
Sponsor:
University of Cincinnati
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCCI-HN-13-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None